CN102083425A - 治疗真菌感染的方法 - Google Patents

治疗真菌感染的方法 Download PDF

Info

Publication number
CN102083425A
CN102083425A CN200980121923XA CN200980121923A CN102083425A CN 102083425 A CN102083425 A CN 102083425A CN 200980121923X A CN200980121923X A CN 200980121923XA CN 200980121923 A CN200980121923 A CN 200980121923A CN 102083425 A CN102083425 A CN 102083425A
Authority
CN
China
Prior art keywords
alkyl
optionally substituted
halogen
aryl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200980121923XA
Other languages
English (en)
Chinese (zh)
Inventor
K·勒维斯
M·D·拉弗勒尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeastern University Boston
Original Assignee
Northeastern University Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeastern University Boston filed Critical Northeastern University Boston
Publication of CN102083425A publication Critical patent/CN102083425A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200980121923XA 2008-04-22 2009-04-22 治疗真菌感染的方法 Pending CN102083425A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4695308P 2008-04-22 2008-04-22
US61/046,953 2008-04-22
PCT/US2009/041403 WO2009132101A1 (en) 2008-04-22 2009-04-22 Methods of treating fungal infections

Publications (1)

Publication Number Publication Date
CN102083425A true CN102083425A (zh) 2011-06-01

Family

ID=40790885

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980121923XA Pending CN102083425A (zh) 2008-04-22 2009-04-22 治疗真菌感染的方法

Country Status (8)

Country Link
US (1) US20120252820A1 (enExample)
EP (1) EP2282730A1 (enExample)
JP (1) JP2011518228A (enExample)
CN (1) CN102083425A (enExample)
AU (1) AU2009239385A1 (enExample)
CA (1) CA2722404A1 (enExample)
MX (1) MX2010011678A (enExample)
WO (1) WO2009132101A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103800437A (zh) * 2013-12-31 2014-05-21 芜湖乐锐思信息咨询有限公司 一种治疗虫霉病的中药

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014130922A1 (en) * 2013-02-25 2014-08-28 Trustees Of Boston University Compositions and methods for treating fungal infections
CN105641678A (zh) * 2014-12-03 2016-06-08 博瑞生物医药（苏州）股份有限公司 阿尼芬净胃肠外制剂及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6505398A (enExample) * 1965-04-28 1966-10-31
IL53440A0 (en) * 1977-11-22 1978-01-31 Teva Pharma 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them
US4923852A (en) * 1987-06-11 1990-05-08 Merck & Co., Inc. Aminoalkyl naphthalenediols as host resistance enhancers against viral infections
FR2631028B1 (fr) * 1988-05-09 1990-07-13 Cird Adamantyl-2 isothiazoline-4 ones-3, leur procede de preparation et leur utilisation comme agents bactericides et fongicides
BR0213235A (pt) * 2002-09-13 2004-09-28 New Pharma Res Sweden Ab Composição e método de potenciação

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103800437A (zh) * 2013-12-31 2014-05-21 芜湖乐锐思信息咨询有限公司 一种治疗虫霉病的中药

Also Published As

Publication number Publication date
AU2009239385A1 (en) 2009-10-29
US20120252820A1 (en) 2012-10-04
WO2009132101A1 (en) 2009-10-29
MX2010011678A (es) 2011-01-21
JP2011518228A (ja) 2011-06-23
CA2722404A1 (en) 2009-10-29
EP2282730A1 (en) 2011-02-16

Similar Documents

Publication Publication Date Title
ES2608285T3 (es) Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
US20150266827A1 (en) Antibiotic Tolerance Inhibitors
US20220184075A1 (en) Pharmaceutical composition containing hdac6 inhibitor as active ingredient for prevention or treatment of itching
US11174267B2 (en) Spiroindolinones and therapeutic uses thereof
BRPI0620040A2 (pt) inibidores de histona desacetilase para realçar a atividade de agentes antifúngicos
KR20140129030A (ko) 캔디다증 및 아스퍼질러스 감염을 치료하기 위한 화합물 및 방법
US20130288956A1 (en) Combined pharmaceutical composition as antifungal agent
AU2008248118A1 (en) Methods of treating fungal infections
US20110319455A1 (en) Antifungal Treatment
US9504688B2 (en) Methods and compositions for treating bacterial infection
US20020193369A1 (en) Antifungal compounds and uses therefor
WO2020117755A1 (en) Compositions and methods for treating biofilms
CN102083425A (zh) 治疗真菌感染的方法
US20170056405A1 (en) Methods and compositions for treating bacterial infection
US20030149088A1 (en) HIV treatment
WO2011035225A1 (en) Synergistic combination therapy
US11331367B1 (en) Compounds and methods for inhibiting protozoan parasites
US11655225B2 (en) Antimycobacterial heterocyclic amides
Simon et al. Preventing Candida albicans biofilm formation using aromatic-rich piperazines
ES2986502T3 (es) Agente antifúngico
KR101432078B1 (ko) 항병원성 활성을 갖는 7-벤질옥시인돌 화합물의 신규한 용도
HK40047620A (en) Novel antimycobacterial heterocyclic amides
HK40060583A (en) Anti-fungal agent
HK40047620B (zh) 新型抗分枝杆菌杂环酰胺

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20110601